Analytical instrument portfolio for clinical diagnostics

Published on: 

Sponsored content

Thermo Scientific’s Medical Device (MD) portfolio of liquid chromatography-mass spectrometry (LC–MS) systems comprises of United States Food and Drug Administration (U.S. FDA) Class I medical devices, including the Vanquish MD High Performance Liquid Chromatography (HPLC) system, TSQ Altis MD Series mass spectrometer and Quantis MD Series mass spectrometer. According to the company, the systems are designed to increase throughput of clinical diagnostic assays for the detection of small to large molecules within complex biological matrices.

Thermo Fisher Scientific, San Jose, CA